Glenmark PharmaceuticalsGLENMARK 
$20.29-0.12%24h
-0.12%24h
Global rank2525
Market cap$5.73B
Change 7d3.99%
YTD Performance99.41%
SP500 benchmarkOutperform
P/E1.93
P/S3.78
Revenue$1.52B
Earnings$44.97M
Dividend yield-
Main Sector
Healthcare
Glenmark Pharmaceuticals (GLENMARK) Total Liabilities
GLENMARK Total Liabilities in 2022: $1.14B
According to Glenmark Pharmaceuticals latest financial reports the total liabilities of GLENMARK is $1.14B, an increase of 24.69% to 2022. At the end of 2022 company had $910.99M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Glenmark Pharmaceuticals is responsible for during its operational activities.
Glenmark Pharmaceuticals (GLENMARK) Total Liabilities History from 2023 to 2022
-
Value:-
GLENMARK Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $1.14B | 24.69% |
| 2022 | $910.99M | -10.47% |
| 2021 | $1.02B | -0.88% |
| 2020 | $1.03B | 28.85% |
| 2019 | $796.67M | - |
View the Top Total Liabilies Stocks
